Opioid and chemokine receptor crosstalk: A promising target for pain therapy?

124Citations
Citations of this article
193Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Chemokines and opioids are important regulators of immune, inflammatory and neuronal responses in peripheral and central pain pathways. Recent studies have provided insights into the functional interactions between chemokine receptors and opioid receptors, and their role in pain modulation. In this Progress article, we discuss how crosstalk between these two systems might provide a molecular and cellular framework for the development of novel analgesic therapies for the management of acute and/or chronic pain.

Cite

CITATION STYLE

APA

Parsadaniantz, S. M., Rivat, C., Rostène, W., & Réaux-Le Goazigo, A. (2015). Opioid and chemokine receptor crosstalk: A promising target for pain therapy? Nature Reviews Neuroscience, 16(2), 69–78. https://doi.org/10.1038/nrn3858

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free